These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2939696)

  • 1. Platelet-derived heparin neutralizing proteins.
    Lane DA
    Adv Exp Med Biol; 1985; 192():427-38. PubMed ID: 2939696
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
    ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
    Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of platelet factor 4 to heparin oligosaccharides.
    Denton J; Lane DA; Thunberg L; Slater AM; Lindahl U
    Biochem J; 1983 Feb; 209(2):455-60. PubMed ID: 6847629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of platelet factor 4 (PF4) on assays of plasma heparin.
    Levine SP; Sorenson RR; Harris MA; Knieriem LK
    Br J Haematol; 1984 Aug; 57(4):585-96. PubMed ID: 6743573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomenclature of secreted platelet proteins--report of the Working Party on Secreted Platelet Proteins of the Subcommittee on Platelets.
    Kaplan KL; Niewiarowski S
    Thromb Haemost; 1985 Apr; 53(2):282-4. PubMed ID: 3161208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of low-affinity platelet factor 4 to beta-thromboglobulin by plasmin and trypsin.
    Holt JC; Niewiarowski S
    Biochim Biophys Acta; 1980 Oct; 632(2):284-9. PubMed ID: 6158345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
    Baruch D; Lindhout T; Wagenvoord R; Hemker HC
    Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of low-molecular-weight heparin on platelets as compared with commercial heparin.
    Cella G; Scattolo N; Luzzatto G; Girolami A
    Res Exp Med (Berl); 1984; 184(4):227-9. PubMed ID: 6494594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of platelet-derived β-thromboglobulins on coagulation.
    Egan K; van Geffen JP; Ma H; Kevane B; Lennon A; Allen S; Neary E; Parsons M; Maguire P; Wynne K; O' Kennedy R; Heemskerk JWM; Áinle FN
    Thromb Res; 2017 Jun; 154():7-15. PubMed ID: 28384443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor X.
    Jackson CM
    Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
    [No Abstract]   [Full Text] [Related]  

  • 17. Location and partial characterization of the heparin-binding fragment of platelet thrombospondin.
    Raugi GJ; Mumby SM; Ready CA; Bornstein P
    Thromb Res; 1984 Oct; 36(2):165-75. PubMed ID: 6568771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of exercise on platelet activation and platelet reactivity.
    Mant MJ; Kappagoda CT; Quinlan J
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Nov; 57(5):1333-7. PubMed ID: 6240477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of platelet factor 4 in plasma.
    Fuster V; Kazmier FJ; Cash JD; Bowie EJ; Owen CA
    Mayo Clin Proc; 1973 Feb; 48(2):103-6. PubMed ID: 4689655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.